ENTERPRISE AI ANALYSIS
Reliability and Performance Stability of Large Language Models in Medical Knowledge Assessment: Evidence from the European Board of Nuclear Medicine Examination
Our in-depth analysis of "Reliability and Performance Stability of Large Language Models in Medical Knowledge Assessment" reveals pivotal insights for enterprise AI integration. This study critically evaluates LLM accuracy and consistency in specialized medical domains, highlighting key considerations for reliable clinical deployment.
EXECUTIVE IMPACT
LLMs Demonstrate Strong, Yet Variable, Performance in Specialized Medical Assessments
The study assessed ten state-of-the-art LLMs on European Board of Nuclear Medicine (EBNM) examination questions, revealing a wide range of accuracy (53.6% to 100%) and significant variability in inter-run reliability (Cohen's κ 0.370–1.000). While all models surpassed a 50% pass threshold, the lack of correlation between high accuracy and consistency highlights critical challenges for enterprise adoption, particularly in high-stakes medical and similar domains. Specifically, mean accuracy ranged from 53.6% to 100.0%, with all models exceeding an illustrative 50% pass threshold. Inter-run reliability varied substantially (κ = 0.370–1.000; mean κ = 0.716). High accuracy did not consistently correspond to high reproducibility; Gemini 2.5 Pro (93.6% accuracy) showed the lowest reliability (κ = 0.370), whereas DeepSeek V3.2 (100% accuracy) demonstrated perfect agreement. No significant correlation between accuracy and reliability was observed (Spearman ρ = 0.394, p = 0.26). LLMs demonstrate strong but heterogeneous performance on high-stakes medical knowledge assessments, highlighting the need for multi-run evaluation and continued validation using non-disclosed examination material.
78.4%
Average Accuracy Across All LLMs
κ 0.370-1.000
Reliability Range
100.0%
Top Performer Accuracy (DeepSeek V3.2)
No Correlation
Accuracy & Reliability (ρ = 0.394, p = 0.26)
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
This category explores the efficacy and stability of large language models in specialized medical examinations, focusing on their ability to accurately and consistently answer complex questions. It delves into the nuances of performance across different model architectures and their implications for clinical and educational applications.
78.4%
Average Accuracy Across All LLMs
100.0%
DeepSeek V3.2 Accuracy and Consistency
| Model Type | Model | Mean Accuracy (%) | Mean Cohen's κ | Reliability Interpretation |
|---|---|---|---|---|
| Open-Source | DeepSeek V3.2 | 100.0 | 1.000 | Almost Perfect |
| Proprietary | Gemini 2.5 Pro | 93.6 | 0.370 | Fair |
| Proprietary | Grok-4 | 87.2 | 0.676 | Substantial |
| Open-Source | Mistral Medium 3.1 | 83.6 | 0.972 | Almost Perfect |
| Proprietary | Claude Sonnet 4.5 | 81.6 | 0.802 | Almost Perfect |
| Open-Source | Qwen3 Max | 80.8 | 0.947 | Almost Perfect |
| Proprietary | GPT-5 Pro | 73.6 | 0.684 | Substantial |
| Proprietary | ERNIE 4.5 Turbo | 67.2 | 0.500 | Moderate |
| Open-Source | Llama 3.3 70B | 64.0 | 0.670 | Substantial |
| Open-Source | Falcon H1-34B | 53.6 | 0.543 | Moderate |
Enterprise Process Flow
High Accuracy
→
Potential Low Reliability
→
Inconsistent Clinical Decisions
→
Need for Multi-Run Evaluation
Implications for Enterprise AI Deployment
The study underscores that while LLMs show promise in specialized medical knowledge, their variable reliability poses significant challenges for enterprise deployment. For high-stakes applications like clinical decision support, consistent and reproducible outputs are paramount. Organizations must prioritize multi-run validation and consider model architecture and training data quality, not just peak accuracy, when selecting LLMs for mission-critical functions. The observed 'memorization' concern with DeepSeek V3.2 also highlights the need for robust testing against truly novel, withheld data to ensure generalizable intelligence rather than mere recall.
Calculate Your Potential AI ROI
Estimate the financial impact and time savings AI could bring to your organization.
Estimated Annual Savings
$0
Hours Reclaimed Annually
0
Your Enterprise AI Implementation Roadmap
A phased approach to integrate AI reliably and effectively into your operations.
Phase 1: Strategic Assessment & Pilot (1-3 Months)
Identify high-impact use cases, conduct feasibility studies, and run small-scale pilots with a focus on measurable outcomes. Establish clear metrics for success and evaluate initial LLM performance with multi-run reliability protocols.
Phase 2: Scaled Deployment & Integration (3-9 Months)
Expand successful pilots, integrate AI solutions with existing enterprise systems, and develop robust data pipelines. Implement continuous monitoring of LLM accuracy and consistency in production environments, ensuring human oversight.
Phase 3: Optimization & Governance (9+ Months)
Refine AI models based on feedback, optimize performance, and establish comprehensive governance frameworks for ethical AI use, security, and compliance. Foster an AI-fluent organizational culture through training and knowledge sharing.
Ready to Transform Your Enterprise with AI?
Book a personalized consultation to discuss how these insights apply to your business and how we can tailor an AI strategy for reliable, impactful results.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat